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Abstract
Background: In the past, molecular mechanisms that drive the initiation of an inflammatory response have been
studied intensively. However, corresponding mechanisms that sustain the expression of inflammatory response
genes and hence contribute to the establishment of chronic disorders remain poorly understood. Recently, we
provided genetic evidence that signaling via the receptor for advanced glycation end products (Rage) drives the
strength and maintenance of an inflammatory reaction. In order to decipher the mode of Rage function on gene
transcription levels during inflammation, we applied global gene expression profiling on time-resolved samples of
mouse back skin, which had been treated with the phorbol ester TPA, a potent inducer of skin inflammation.
Results: Ranking of TPA-regulated genes according to their time average mean and peak expression and
superimposition of data sets from wild-type (wt) and Rage-deficient mice revealed that Rage signaling is not
essential for initial changes in TPA-induced transcription, but absolutely required for sustained alterations in
transcript levels. Next, we used a data set of differentially expressed genes between TPA-treated wt and Rage-
deficient skin and performed computational analysis of their proximal promoter regions. We found a highly
significant enrichment for several transcription factor binding sites (TFBS) leading to the prediction that
corresponding transcription factors, such as Sp1, Tcfap2, E2f, Myc and Egr, are regulated by Rage signaling.
Accordingly, we could confirm aberrant expression and regulation of members of the E2f protein family in
epidermal keratinocytes of Rage-deficient mice.
Conclusions: In summary, our data support the model that engagement of Rage converts a transient cellular
stimulation into sustained cellular dysfunction and highlight a novel role of the Rb-E2f pathway in Rage-dependent
inflammation during pathological conditions.
Background
A striking feature of many human cancers is an underly-
ing and unresolved inflammation, which often predates
the disease and orchestrates a tumor supporting micro-
environment. Indeed, several lines of evidence, including
population-based epidemiological and clinical studies as
well as experimental animal model systems, highlighted
chronic infection and persistent inflammation as major
risk factors for various types of cancer [1,2]. Thus, mole-
cular mechanisms converting a transient inflammatory
tissue reaction into a tumor promoting microenviron-
ment as well as signaling and gene regulatory networks
implicated in cellular communication between tumor
and immune cells will be auspicious targets for innova-
tive strategies of translational cancer research.
Recently, we could show that the receptor for
advanced glycation end products (Rage) drives the
strength and maintenance of inflammation during
tumor promotion in a mouse model of inflammation-
associated skin carcinogenesis [3]. Accordingly, tumor
f o r m a t i o ni nm u t a n tm i c ew i t hRage deletion (Rage
-/-)
was impaired in this model, but also in a tumor model
of colitis-induced colon cancer [3,4].
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receptor of the immunoglobulin super-family with low
expression levels in most adult tissues. However, Rage
expression increases at sites of inflammation, mainly on
inflammatory cells, endothelial cells and epithelial cells,
and propagates cellular dysfunction in numerous inflam-
mation-related pathological states, such as diabetes, vas-
cular disease, neurodegeneration, chronic inflammation,
and cancer [5-7].
With respect to Rage signaling, several target genes
have been identified in the past, including pro-
inflammatory mediators, matrix metalloproteinases, and
adhesion proteins, however, their expression critically
depends on the cell type, its microenvironment, and
quality of the stimulus [8]. In the process of neoplastic
transformation and malignant progression, activation of
Rage by its ligands, such as advanced glycation end pro-
ducts (AGEs), high mobility group box-1 (Hmgb1), and
members of the S100 protein family, can stimulate
tumor cell proliferation, invasion, chemoresistance, and
metastasis [9-11]. Rage ligands derived from cancer cells
can also support the establishment of a pro-tumorigenic
microenvironment by activation of leukocytes, vascular
cells, fibroblasts, and modulation of immune tolerance
[11]. Although multiple intracellular signaling pathways,
including MAP kinases, Rho GTPases, PI3K, JAK/STAT,
and NF-B, have been found to be altered following
Rage stimulation, the molecular mechanisms how Rage
triggers intracellular signaling to regulate cellular deci-
sions remain largely elusive, and the identity of direct
signaling molecules downstream of the receptor are still
unknown [5,12-14].
In order to elucidate how Rage receptor signaling con-
verts a transient stimulus into a long lasting response,
global gene expression kinetics were recorded with skin
samples of wt and Rage
-/- mice upon TPA stimulation.
We applied a recently published computational analysis
tool that enables a global, holistic view on cellular
responses over a time frame of hours based on dynamic
transcription level data [15], and identified the charac-
teristic duration and temporal order of transient and
Rage-dependent events upon TPA stimulation. Subse-
quently, a computational approach was applied to pre-
dict transcription factors that are implicated in the
Rage-dependent regulation of pro-inflammatory gene
expression, and thus, to identify novel key molecules as
putative targets for innovative strategies of anti-
inflammatory therapy.
Results
Identification of Rage-dependent gene expression upon
TPA treatment of mouse back skin
In order to identify alterations in the gene expression
profile during the process of skin inflammation we
applied TPA on the back skin of wt and Rage
-/- mice
and prepared total RNA at consecutive time points after
treatment (6, 12, 24, and 48 hours following TPA appli-
cation in three individual animal experiments). The
RNA was hybridized on whole mouse genome oligonu-
cleotide microarrays followed by feature extraction and
quantile normalization procedure (Figure 1A). The gene
fold expression was calculated with respect to non-
treated controls (0 h), and TPA-responsive genes in
samples of wt back skin were ranked according to their
combined averaged mean and peak expression within
the experimental time window of 48 hours for each
individual kinetic series. Subsequently, we identified a
common subset of 341 genes among the 1,000 highest
ranked genes in all three experiments with a small var-
iance between the experiments (Figure 1B and see Addi-
tional file 1). These genes were further separated into
six expression profile sets according to k-means cluster-
ing (see Additional file 2). Most candidate genes were
found in cluster 3 (n = 125) or in cluster 6 (n = 84),
representing genes that weree i t h e rT P A - r e p r e s s e do r
TPA-induced within 6 hours and maintained altered
expression for at least 24 hours (Figure 1C). Interest-
ingly, when we considered the transcript levels of these
genes in Rage
-/- back skin and superimposed both wt
and Rage
-/- data sets we found a comparable response in
both genotypes at 6 hours. However, initial transcript
level responses ceased to basal levels in Rage
-/- skin
between 12 and 24 hours upon stimulation, whereas the
response was sustained in wt animals. Our data suggest
the existence of two phases of the TPA response: an
initial Rage-independent response that is followed by a
second Rage-dependent maintenance of the altered tran-
script levels (Figure 1C).
Next, linear models with empirical Bayesian correction
were applied to identify differentially expressed genes
between wt and Rage
-/- back skin at the investigated
time points after TPA administration. In line with pre-
ceding analyses and previous results [3], genes (n = 122)
that differ significantly between both genotypes were
only found 24 hours after TPA stimulation (see Addi-
tional file 3). According to their temporal expression
pattern, differentially expressed genes were further
divided by unsupervised hierarchical clustering of their
correlation distance (one minus the Pearson correlation
coefficient) into three sub-clusters. While cluster 1 (n =
52) and cluster 2 (n = 25) shared TPA-induced genes,
cluster 3 (n = 45) was composed of TPA-repressed
genes (see Additional file 3). We selected several differ-
entially expressed genes (Tgfb1, Tnf, Fosl1, Mmp2, Irf7,
Hmgb2,a n dHdac2)a n dc o u l dc o n f i r ma l t e r e dt r a n -
script levels by quantitative real-time PCR using cDNA
from back skin of wt and Rage
-/- mice 24 hours after
TPA treatment (see Additional file 4). With regard to
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Page 2 of 13Figure 1 Global gene expression analysis of wt and Rage
-/- skin following single TPA treatment. (A) Mice of respective phenotypes were
treated once with TPA, and back skin was isolated 6, 12, 24, or 48 hours after stimulation. Non-treated and acetone-treated mice served as
control (0). Global gene expression analysis of RNA samples was performed on whole mouse genome oligonucleotide microarrays (n = 3 for
each genotype and time point). (B) Following quantile normalization, wt genes of each kinetic from three independent animal experiments (1, 2,
and 3) were ranked according to high mean and peak expression separately to filter for TPA-responsive genes. A common subset of 341 genes
was identified out of the top 1000 ranked genes within each kinetic. (C) K-means clustering revealed 6 clusters of which cluster 3 and 6 shared
most genes (for cluster 1, 2, 4, and 5 see Additional file 2). Black lines represent transcript levels of TPA-regulated genes in wt samples and red
lines represent the corresponding genes in Rage
-/- samples.
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Page 3 of 13their functional annotation, genes of cluster 1 were cor-
related with immune effector process, tissue remodeling
and cell signaling, while genes of cluster 3 showed evi-
dent connection to histone and chromatin modifications
as well as metabolic processes (data not shown).
Taken together, time-resolved global gene expression
analysis of wt and Rage
-/- skin upon TPA application
disclosed expression patterns that subdivide the TPA-
induced response into an initial Rage-independent phase
and a second Rage-dependent maintenance of the estab-
lished signal. Differentially expressed genes 24 hours
after TPA stimulation revealed three gene clusters char-
acterized by distinct functions.
Prediction of transcription factors implicated in the Rage-
dependent gene regulatory network
In order to identify relevant transcription factors impli-
cated in the regulation of Rage-dependent genes we per-
formed an in silico promoter analysis. We used the probes
that were differentially expressed between wt and Rage
-/-
mice at the time point 24 hours after TPA application and
selected those that mapped unambiguously to one Entrez-
gene-ID and for which the promoter sequence was avail-
able (n = 97). These probes were clustered by their
correlation distance within the samples from t = 24 hours
into three clusters (see Additional file 5). We analyzed
2 kb upstream and downstream sequences of the anno-
tated transcriptional start site and calculated the enrich-
ment of transcription factor binding sites (TFBS)
compared to all other available genes represented on the
m i c r o a r r a yb yF i s h e r ’s exact tests. The analysis revealed
several highly enriched TFBS for Specificity protein 1 and
4 (Sp1 and 4), Activator protein 2 (Ap2/Tcfap2), E2-pro-
moter-binding factor (E2f), Myc-associated zinc-finger
protein and Myc-associated zinc-finger protein-related
protein (Mazr), Early growth response factor (Egr), CAC-
binding protein (CAC-bp), v-Myc myelocytomatosis viral
oncogene homolog (Myc), Nuclear receptor subfamily 2
group F members (Nr2f/COUP-TF), and Wilms tumor 1
homolog (Wt1) (Table 1). The enrichment tests were also
Table 1 In silico promoter analysis of differentially expressed genes 24 hours after TPA stimulation
Genes BF Name Fischertest P.Val Corrected P.Val With PWM cluster Without PWM cluster
all Sp1 5.33E-07 1.06E-04 94 3
Sp1 isoform 1 5.33E-07 1.06E-04 94 3
Sp4 1.72E-06 2.27E-04 83 14
AP-2beta 1.24E-06 1.22E-03 77 20
AP-2alpha 1.60E-05 1.27E-03 79 18
AP-2gamma 2.13E-05 1.41E-03 79 18
MAZR 6.03E-05 3.41E-03 74 23
CAC-binding protein 1.32E-04 6.52E-03 81 16
Egr-1 3.56E-04 1.56E-02 85 12
Egr-3 4.38E-04 1.73E-02 78 19
E2F 4.85E-04 1.75E-02 58 39
c-Myc 7.31E-04 2.41E-02 67 30
Egr-2 9.69E-04 2.94E-02 80 17
COUP-TF1 1.06E-03 2.94E-02 89 8
WT1 1.19E-03 2.94E-02 67 30
WT1-isoform1 1.19E-03 2.94E-02 67 30
COUP-TF2 1.45E-03 3.38E-02 48 49
Cluster 1 Sp4 2.01E-06 7.93E-04 40 2
Sp1 6.13E-05 6.86E-03 42 0
Sp1 isoform 1 6.13E-05 6.86E-03 42 0
MAZR 6.93E-05 6.86E-03 36 6
HNF-4alpha7 1.84E-04 1,46E-02 29 13
CAC-binding protein 3.12E-04 2.06E-02 38 4
Cluster 2 MAZR 2.14E-04 7.64E-02 19 1
WT1 5.79E-04 7.64E-02 18 2
WT1-isoform1 5.79E-04 7.64E-02 18 2
Cluster 3 E2F 1.88E-05 7.45E-03 28 8
E2F-1 8.50E-05 1.68E-02 28 8
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t h eq u e s t i o n ,w h e t h e rs p e c i f i cT F B Sw e r es i g n i f i c a n t l y
associated with differentially expressed genes in distinct
clusters. While TFBS for Mazr were enriched in promoters
of genes of at least 2 of 3 clusters, a significant correlation
of TFBS for Sp1, Sp4, Hnf4, and CAC-bp were only found
for promoters of genes in cluster 1 (Figure 2A). Similarly,
significant enrichment of TFBS for Wt1 was restricted for
gene promoters in cluster 2, and TFBS for E2f were lim-
ited to gene promoters in cluster 3 (Figure 2A).
In summary, the enrichment analyses highlighted the
putative involvement of several transcription
factors, such as E2f and Wt1, that were previously not
associated with Rage signaling, and therefore, represent
an exciting starting point for further investigation.
Impact of Rage on the regulation of E2f proteins in TPA-
treated skin
To confirm our prediction on transcription factors
implicated in Rage-dependent gene transcription, we
investigated the expression and regulation of the E2f
transcription factor that is well known to determine cel-
lular responses to growth factors, stress and differentia-
tion signals, as well as DNA damage [16]. E2f represents
a family of eight transcription factors that are further
subdivided into a group of potent transcriptional
Figure 2 In silico promoter analysis of differentially expressed genes 24 hours after TPA treatment. (A) Annotated promoter sequences
of 97 differentially expressed genes between wt and Rage
-/- skin were screened for significant enrichment of transcription factor binding sites
(TFBS). TFBS were grouped according to their enrichment within clusters of differentially expressed genes between wt and Rage
-/- skin 24 hours
after TPA treatment. (B) Protein expression of E2f1, E2f4, Rb, and Rbl1 was investigated by Western blot analysis with whole cell lysates of TPA-
and control-treated back skin of wt and Rage
-/- mice. Actin protein levels served as control for protein quality and quantity.
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Page 5 of 13activators (E2f1-3a) and a group of preferential tran-
scriptional repressors (E2f3b, E2f4-8) [17]. Analysis of
our global gene expression data revealed no major
alteration in transcript levels of most E2f family mem-
bers between both genotypes, suggesting an impact of
Rage on posttranslational regulation of E2f proteins.
Interestingly, we found strong induction in protein
levels of E2f1, a representative for the group of tran-
scriptional activators, 6 and 12 hours after TPA applica-
tion in skin lysates of both genotypes. However,
enhanced protein levels 24 hours after TPA stimulation
were only detected in wt lysates (Figure 2B). E2f4, a
representative for the group of transcriptional repres-
sors, gradually increased upon TPA treatment, showing
ap e a ka t2 4h o u r si nwt skin, while no alterations in
protein level were detected in Rage
-/- samples through-
out the kinetic (Figure 2B). Retinoblastoma (Rb) and
retinoblastoma-like (Rbl) proteins regulate the activity of
E2f transcription factors [16]. We found changes for Rb
protein expression with highest levels 6 hours after sti-
mulation in wt skin samples and 24 hours in Rage
-/-
skin samples (Figure 2B). Rbl1 protein expression was
induced in wt and Rage
-/- skin samples following TPA
stimulation, but a concerted increase over time was only
detected for wt animals. Together, these data support
the conception that the Rb-E2f pathway is downstream
of Rage signaling and critically contributes to
altered gene transcription during TPA-induced skin
inflammation.
Immunohistochemical staining was performed on tis-
sue sections of wt and Rage
-/- back skin upon single
TPA treatment in order to investigate whether keratino-
cytes were the cellular origin of altered E2f protein
levels. While slight staining for E2f1 protein was
detected in keratinocytes of control-treated wt back
skin, intense nuclear staining was found in kerationcytes
upon TPA stimulation (Figure 3A-E). A similar staining
pattern for E2f1 protein was observed in control-treated
Rage
-/- back skin and 6 hours after TPA administration,
however, less intense staining was determined at later
time points (Figure 3F-J). Immunohistochemical analysis
of E2f4 protein revealed a strong but transient induction
in the cytoplasm of keratinocytes of wt back skin 12
hours after TPA stimulation, followed by translocation
of E2f4 protein into the nucleus by 24 hours after TPA
application (Figure 3K-O). Again, an obvious change in
E2f4 protein expression was detectable in Rage
-/- back
skin (Figure 3P-T). These data are in clear accordance
with our immunoblot data and demonstrate a direct
correlation between RAGE signaling and E2f-dependent
gene expression in epidermal keratinocytes upon TPA-
induced skin inflammation. Finally, we also determined
Rb, Rbl1, and Rbl2 protein levels by immunochisto-
chemistry. While no major alteration in Rbl2 protein
levels was observed following TPA stimulation or
between both genotypes (see Additional file 6), we
found a stronger staining for Rb and Rbl1 proteins in
keratinocytes of TPA-treated wt compared to Rage
-/-
back skin (Figure 4).
Discussion
The aim of our study was to highlight the molecular
mechanism how Rage signaling contributes to the
dynamic long-term gene regulatory response under phy-
siological and pathological conditions of inflammation.
We selected the model of TPA-induced inflammation
on mouse back skin since it allows a highly reproducible
and temporal analysis of altered gene expression during
acute phase inflammation, including the initiation as
well as the resolution phase. Furthermore, we recently
provided experimental evidence that Rage
-/- mice are
defective in the establishment and maintenance of der-
mal inflammation upon TPA stimulation accompanied
by impaired tumor formation in a chemically induced
skin tumor model [3]. Finally, it is worthwhile to note
that Rage and its ligands are expressed or induced in
numerous cell types, including keratinocytes, immune
cells and endothelial cells [5]. With regard to this com-
plex autocrine and paracrine signaling, in vitro
approaches to identify the role of Rage signaling on
gene regulatory networks under pathological conditions
are almost impossible.
Global profiling of gene expression kinetics with sam-
ples from TPA-treated wt mice revealed a comprehen-
sive list of differentially expressed genes that were
strongly induced or repressed within 6 hours and main-
tained altered transcript levels for at least 24 hours.
Intriguingly, most of these genes exhibited similar
changes in expression at early time points, but rapidly
returned to basal levels in the absence of Rage, provid-
ing experimental evidence that Rage is not necessarily
required to initiate gene regulation in TPA-induced skin
inflammation. However, Rage is absolutely required to
maintain altered expression of genes implicated in
immune effector processes, cell signaling, as well as his-
tone and chromatin organization, and thereby sustains
the tissue response.
Our data fit into the model that engagement of Rage
converts a transient cellular stimulation into sustained
cellular dysfunction. An important driver of this conver-
sion is the long-term activation of pro-inflammatory
transcription factors, especially NF-B, which represents
a key feature of most intracellular signaling pathways
that have been described downstream of Rage stimula-
tion [6,8,18]. However, we hypothesized that in addition
to NF-B other transcription factors contribute to Rage-
dependent modulation of the gene regulatory network.
Obviously, most genes with a significant difference in
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-/- back skin were
detectable 24 hours after TPA administration due to the
effect of Rage on the temporal expression pattern. Com-
putational analysis of TFBS in proximal promoter
regions of differentially expressed genes allowed predic-
tion of specific transcription factors that act downstream
of Rage signaling during TPA-induced inflammation. In
line with our data, a couple of recent studies describe a
direct link between Rage signaling and Egr-1 activation
in endothelial cells and liver cells [19-22]. In this con-
text, Egr-1 was found in the physiological response to
hypoxia and stress signals by direct up-regulation of
inflammatory and pro-thrombotic genes. Moreover, a
systems biology approach with human monocytes trea-
ted with the immunomodulatory peptide LL-37 revealed
an involvement of Ap2, Sp1, E2f and Egr in gene regula-
tion during conditions based on innate immunity [23].
Our data also predict that these transcription factors
seem to be co-activated by various conditions of
inflammation and synergize with well-known pro-
inflammatory transcription factors such as NF-Ba n d
AP-1 in a Rage-dependent manner. It is worth to note
Figure 3 E2f1 and E2f4 protein expression in skin following a single TPA stimulus. Tissue sections of acetone- (Ac) or TPA-treated (6, 12,
24, and 48 hours) back skin from wt and Rage
-/- mice were analyzed by immunohistochemical staining using E2f1- and E2f4-specific antibodies.
Representative images of at least 2 animals of each genotype and time point are shown with red staining for E2f1 or E2f4 and counterstaining
with hematoxylin. Scale bar = 25 μm.
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Page 7 of 13that TFBS for Sp1, Ap2, and Egr are also present in the
promoter of Rage [24,25], suggesting a positive feedback
loop by up-regulation of the receptor, which ensures
maintenance and amplification of cellular activation in
settings where ligands of Rage accumulate. A similar
scenario has been described for NF-B, which also
represents a target of Rage signaling and activator of
Rage expression [5,6].
Interestingly, our analysis revealed a significant enrich-
ment of TFBS for the transcription factor E2f. There
are a number of findings demonstrating diverse
transcriptional regulation of E2f-responsive genes, sug-
gesting that expression of these genes is regulated by
different sets of Rb-E2f protein complexes [16]. How-
ever, it is currently uncertain how individual E2f mem-
bers recognize a particular E2f-binding site during cell
cycle progression or differentiation. One possibility is
that the DNA-binding specificity of E2f members is
influenced by other transcriptional regulatory factors,
such as Sp1, that bind to sites contiguous to the E2f-
binding site [26,27]. We found TPA-induced protein
levels for E2f1 and E2f4 in epidermal keratinocytes of wt
Figure 4 Rb and Rbl1 protein expression in skin following a single TPA stimulus. Tissue sections of acetone- (Ac) or TPA-treated (6, 12, 24,
and 48 hours) back skin from wt and Rage
-/- mice were analyzed by immunohistochemical staining using Rb- and Rbl1-specific antibodies.
Representative images of at least 2 animals of each genotype and time point are shown with red staining for Rb or Rbl1 and counterstaining
with hematoxylin. Scale bar = 25 μm.
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regulation of Rb1 and Rbl1, suggesting the formation of
Rb-E2f protein complexes. In contrast to wt mice,
induction of E2f and Rb family proteins was impaired or
only transient in keratinocytes of TPA-treated Rage
-/-
back skin. Rb family proteins associate with a wide
range of chromatin remodeling proteins forming tran-
scriptional repressor complexes [28]. Thus, the existence
of Rb-E2f complexes in keratinocytes after TPA stimula-
tion could explain the enrichment of TFBS for E2f in
the gene set characterized by strong and sustained
repression. In addition to control of gene expression
and binding to inhibitory Rb proteins, the activity of
E2F proteins is tightly regulated by post-translational
modification and regulation of protein turnover [29].
As an example, free E2F1 and E2F4 proteins are
unstable due to ubiquitination and proteasomal degra-
dation. Numerous cellular proteins have been
described to regulate E2F protein ubiquitination, such
as the CK1-MDM2 complex [30,31], ARF proteins
(p14ARF in human and p19ARF in the mouse; [32]),
Set9 and LSD1 [33]. However, our analysis did not
reveal major changes in expression of any of these reg-
ulators upon TPA application or between RAGE-defi-
cient mice and controls, and a functional link between
RAGE signaling with one of these proteins has not
been documented to the best of our knowledge. Iva-
nova and colleagues reported that in differentiating
keratinocytes calcium-induced protein kinase C (PKC)
activation reduces E2F1 protein level, which requires
activation of novel PKC isoforms by the MAP kinase
p38 [34]. Again E2F1 down-regulation in differentiat-
ing keratinocytes involves its ubiquitination and pro-
teosomal degradation subsequent to CRM1-dependent
nuclear export and degradation of E2F1 during differ-
entiation [35]. Indeed, we observed strong cytoplasmic
staining for E2F1 protein 12 hours after TPA treat-
ment in keratinocytes of Rage
-/- mice and wt controls.
However, in contrast to wt controls, which show
obvious nuclear staining for E2F1 until 48 hours after
treatment, nuclear staining in keratinocytes of Rage
-/-
mice was hardly visible at any time point, suggesting
that RAGE signaling might regulate nuclear-cytoplas-
mic shuttling of E2F proteins.
Finally, our data predict that the Rb-E2f pathway and
its target genes not only act downstream of Rage signal-
ing, but also might be pivotal for the process of skin
inflammation upon TPA treatment. Indeed, CDK activ-
ity, which is up-stream of Rb-E2f, was recently corre-
lated with roles in inflammatory cell differentiation,
adhesion and recruitment as well as cytokine production
and inflammatory signaling [36]. Intriguingly, CDK inhi-
bitor drugs that are well-known to impair cell cycle pro-
gression in tumor cells have emerged recently as
potential anti-inflammatory, pharmacological agents by
influencing the resolution of inflammation [36,37].
Conclusions
In summary, our approach to combine gene expression
profiling with computational analysis did not only high-
light the topology of Rage-dependent gene regulation in
skin inflammation, but also allowed the prediction of
novel transcription factors downstream of Rage signaling
(Figure 5). A major challenge in the future will be the inte-
gration of known and newly identified transcription factors
in a common model of Rage-dependent signaling network
and to predict a dynamic program of inflammation in set-
tings of physiological as well as pathological conditions.
Methods
Animal work and sample preparation
Rage
-/- animals were described previously [38], and wt
controls were obtained from Charles River Laboratories.
Mice were housed and treated with TPA as described
previously [3]. In short, 10 nmol TPA/100 μl Acetone
was applied to the shaved dorsal back skin and mice
were sacrificed at indicated time points. Mice receiving
acetone or no treatment served as controls. The proce-
dures for performing animal experiments were in accor-
dance with the principles and guidelines of the
‘Arbeitsgemeinschaft der Tierschutzbeauftragten in
Baden-Württemberg’ and were approved by the ‘Regier-
ungspräsidium Karlsruhe’, Germany (AZ 129/02).
Skin necropsies for RNA or protein preparation were
immediately frozen in liquid nitrogen after isolation. For
histological analysis, tissues were fixed with 4% parafor-
maldehyde (PFA) in PBS pH 7.4, paraffin embedded,
and cut into 6 μm sections as described previously [3].
Tissue sections were stained with hematoxylin-eosin and
were examined by several experienced experimenters.
RNA preparation
Total RNA extraction from mouse back skin of
untreated, 24 hours acetone- and 6, 12, 24, 48 hours
TPA-treated wt and Rage
-/- mice was performed accord-
ing to the manufacturer’s instructions using peqGOLD
RNAPure™ Reagent (Peq Lab, Erlangen, Germany). For
RNA integrity and degradation analysis, the 2100 BioA-
nalyzer (Agilent Technologies, Santa Clara, CA) with
RNA 6000 Nano LabChip Kit was used according to the
manufacturer’s instructions. Only RNA preparations
with a RNA Integrity Number (RIN) of at least seven
were used for microarray analysis.
Microarray analysis
Global gene expression analysis was performed on
4x44K whole mouse genome one-color 60-mer oligonu-
cleotide microarrays (Agilent Technologies) containing
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Page 9 of 1341,174 unique probes. For amplification and single-color
labeling of 1 μgR N A ,t h eL o wR N AI n p u tL i n e a r
Amplification Kit and the One-Color RNA Spike-in Kit
(Agilent Technologies, Santa Clara, CA) were used
according to the manufacturer’s protocol. Upon hybridi-
zation, microarray read out was accomplished in the
Agilent Scanner G25505B (Agilent Technologies, Santa
Clara, CA) with 5 μm resolution and automatically
adjusting PMT voltages according to manufacturer’s
specification. Data processing was performed using Fea-
ture Extraction FE V9.5 Image Analysis software (Agi-
lent Technologies, Santa Clara, CA) as recommended by
the manufacturer.
Quantitative real-time polymerase chain reaction analysis
Quantitative real-time polymerase chain reaction analy-
sis was performed as described previously [3]. Primers
used for RQ-PCR analysis are listed in Additional file 7.
Target gene cycle of threshold values were normalized
to the corresponding cycle of threshold values of using
the change in cycle of threshold method.
Statistical analysis
Array data were normalized by the quantile method [39],
in combination with the “normexp” background correc-
tion implemented in Limma [40], and log2-transformed.
Differentially expressed genes were identified by applying
a linear model with the factors “time point” and “geno-
type”, and subsequent empirical Bayesian correction [40].
For each time point t, the following contrast was calcu-
lated: (Ir,t - Ir-0)-( Iw,t - ww,0), where I is the logarithm of
the vector of intensities, indices r and w refer to Rage
-/-
and wt mice, respectively, and 0 is the control condition
(t =0 ) .P-values from the F test of the linear model were
adjusted for multiple testing by the method of Benjamini
and Hochberg [41]. All adjusted P-values < 0.05 were
considered significant. All calculations were carried out
in R version 2.6.2 http://www.R-project.org and Limma
Figure 5 Model of physiological and pathological functions of RAGE signaling. Combination of gene expression profiling and
computational approaches revealed that RAGE is not necessary for the initial response after stimulation, but absolute required for sustaining
altered gene transcription. This is mainly due to the impact of RAGE-mediated signaling on expression and activity of transcription factors such
as E2F. Thereby, RAGE modulates the kinetic of transcript levels of genes implicated in tissue homeostasis, inflammation, and cancer.
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Page 10 of 13version 2.12.0. A list of differentially expressed genes at
24 hours after TPA stimulation is given in Additional
file 3.
In order to further assess the dynamic response of the
gene regulation upon TPA stimulation, we ranked the
gene expression kinetics according to the peak and
mean fold expression of each genes within the experi-
mental time window of 48 hours [15]. Fold expression
of each gene was calculated with respect to the control
condition of wt and Rage
-/- animals. Next, a rank score s
was defined for every gene as sF E F E tp =+
22 ,w h e r e
FEi = 〈gi(t)〉T and, FEp denote the time-averaged mean
and peak gene fold expression (FE) of the gene’st i m e
series, respectively, normalized to the maximal peak and
maximal mean fold expression of all measured genes.
Gene ranking was performed separately for the three
biological replicates of the TPA stimulation. Taking the
1,000 genes having the highest rank score s in each
replicate, a set of 341 genes common to all rank lists
was identified for further analysis (Additional file 1).
Taking the top 500, 2,000 or 3,000 genes did not change
the quality of the results. Subsequent k-means clustering
of these 341 wt expression profiles was performed and
expression levels of the same genes in Rage
-/- samples
were superimposed. Pathway analysis was accomplished
by using web-based DAVID [42,43].
In silico promoter analysis
All available promoter sequences of murine genes repre-
s e n t e do nt h ew h o l em o u s eg e n o m em i c r o a r r a yw e r e
extracted from NCBI Entrezgene database ([44]; down-
load: June 19th, 2008). Putative transcription factor bind-
ing sites (TFBS) were scanned within 2 kb upstream and
downstream of the annotated transcriptional start site
utilizing a position-weight matrix (PWM) scan as imple-
mented in cureos package v0.3 ([45]; http://www.bepress.
com/sagmb/vol2/iss1/art7) and described in Westermann
et al. [46] for R open-source software http://www.R-pro-
ject.org. PWMs were taken from the TRANSFAC data-
base ([47]; release: January 12th, 2008). P-values for each
PWM were obtained by comparing their scores to those
of 1,000 random 4 kb sequence permutations. A general
P-value cut-off of p < 0.1 was set as a reasonable compro-
mise between false-positives and false-negatives. The
genes that were differentially expressed between wt and
Rage
-/- mice at the time point 24 hours after TPA appli-
cation were divided into three sub-clusters with different
gene expression profiles by unsupervised hierarchical
clustering within samples at the time point t = 24 hours
(complete linkage, the distance was calculated by one
minus the Pearson correlation coefficient). Fisher’s exact
tests were performed to determine enrichments of PWM
hits (counting genes with ≥ 1 significant score as a hit)
for each cluster as compared to all other genes repre-
sented on the microarray. All P-values were Benjamini-
Hochberg-corrected for multiple testing.
Western Blot analysis
Western Blot analyses were performed with whole cell
lysates from mouse back skin with antibodies listed in
Additional file 8 according to the manufacturer’s
instructions. Whole cell lysates were prepared with
RIPA buffer (50 mM Tris-HCL pH 8, 150 mM NaCl,
0.1% SDS, 0.5% deoxylacid Na
+-salt, 1% NP-40).
Immunohistochemistry analysis
Immunohistochemistry staining was performed on back
skin sections from wt and Rage
-/- mice with the Immu-
nodetection Kit (Vector Laboratories; Burlingame, CA)
according to the manufacturer’s instructions. Primary
and secondary antibodies used are listed in Additional
file 8.
Additional material
Additional file 1: Table with 341 TPA-responsive genes in back skin
of wt mice.
Additional file 2: K-means clustering of TPA-responsive genes.K -
means clustering of common TPA-responsive genes in the kinetics of
three independent experiments with wt animals revealed 6 clusters.
Cluster 1 (n = 5), cluster 2 (n = 45), cluster 3 (n = 125), cluster 4 (n = 71),
cluster 5 (n = 11), and cluster 6 (n = 84). Black lines represent transcript
levels of genes in wt skin samples. Red lines represent transcript levels in
Rage
-/- skin samples.
Additional file 3: Table of 122 genes differentially expressed 24
hours after TPA stimulation.
Additional file 4: Quantitative real-time PCR of differentially
expressed genes 24 hours after TPA treatment. Relative transcript
levels of differentially expressed genes were determined by quantitative
real-time PCR with cDNA derived from wt and Rage
-/- back skin 24 hours
upon TPA treatment. Transcript levels for genes of interest were
determined in triplicates with wt and Rage
-/- cDNA samples and
normalized to Hprt transcript levels. Next, expression values of genes of
interest derived from wt cDNA were set to one and bars represent
relative transcript levels for Rage
-/- cDNA samples. Similar data were
obtained for two independent biological replicates (data not shown).
Additional file 5: Cluster dendrogram of genes differentially
expressed at t = 24 hours. Clustering was done only over samples
from t = 24 hours via Person correlation distance, complete linkage
algorithm. Three clusters were defined from the dendrogram.
Additional file 6: Rbl2 protein expression in skin following a single
TPA stimulus. Tissue sections of acetone- (Ac) or TPA-treated (6, 12, 24,
and 48 hours) back skin from wt and Rage
-/- mice were analyzed by
immunohistochemical staining using Rbl2-specific antibodies.
Representative images of at least 2 animals of each genotype and time
point are shown with red staining for Rbl2 and counterstaining with
hematoxylin. Scale bar = 25 μm.
Additional file 7: Table of primer sequences used for quantitative
real-time PCR analysis.
Additional file 8: Table of primary antibodies used for Western Blot
(WB) and immunohistochemistry analysis (IHC).
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